Prevention of occupational exposure to human immunodeficiency virus 1
Breeling, J.L.
Comprehensive Therapy 19(4): 145-150
1993
ISSN/ISBN: 0098-8243 PMID: 8261768 Document Number: 410232
Document emailed within 1 workday
Related Documents
Le Pont, F.ço.; Hatungimana, V.; Guiguet, M.; Ndayiragije, A.; Ndoricimpa, J.; Niyongabo, T.; Larouzé, B. 2003: Assessment of occupational exposure to human immunodeficiency virus and hepatitis C virus in a referral hospital in Burundi, Central Africa Infection Control and Hospital Epidemiology 24(10): 717-718Landers, M.B.; Fraser, V.J. 1997: Antiviral chemoprophylaxis after occupational exposure to human immunodeficiency virus: why, when, where, and what American Journal of Ophthalmology 124(2): 234-239
Aggarwal, V.; Seth, A.; Chandra, J.; Gupta, R.; Kumar, P.; Dutta, A.Kumar. 2012: Occupational exposure to human immunodeficiency virus in health care providers: a retrospective analysis Indian Journal of Community Medicine: Official Publication of Indian Association of Preventive and Social Medicine 37(1): 45-49
Calfee, D.P. 2006: Prevention and management of occupational exposures to human immunodeficiency virus (HIV) Mount Sinai Journal of Medicine new York 73(6): 852-856
Wen, Y.; Guan, J.; Wu, Z.; Li, L.; Rotheram-Borus, M.Jane.; Lin, C.; Detels, R. 2009: Pharmacy workers' sexually transmitted diseases/human immunodeficiency virus knowledge in Fuzhou, China: implications for human immunodeficiency virus testing, treatment, and prevention strategies Sexually Transmitted Diseases 36(4): 221-226
Kline, M.W.; Lewis, D.E.; Hollinger, F.B.; Reuben, J.M.; Hanson, L.C.; Kozinetz, C.A.; Dimitrov, D.H.; Rosenblatt, H.M.; Shearer, W.T. 1994: A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection Pediatric Infectious Disease Journal 13(2): 90-94
Koyanagi, A.; Humphrey, J.H.; Ntozini, R.; Nathoo, K.; Moulton, L.H.; Iliff, P.; Mutasa, K.; Ruff, A.; Ward, B.; Chidawanyika, H.; Hargrove, J.; Mahomva, A.I.; Majo, F.; Malaba, L.C.; Mbizvo, M.T.; Mzengeza, F.; Ndhlovu, M.; Piwoz, E.; Propper, L.; Rambanepasi, P.; Ruff, A.J.; Tavengwa, N.; Zijenah, L.S.; Zunguza, C.D.; Zvandasara, P. 2011: Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy Pediatric Infectious Disease Journal 30(1): 45-51
Polis, M.A. 1990: Occupational transmission of human immunodeficiency virus Ear Nose and Throat Journal 69(6): 401-405
Keller, M.J.; Klotman, M.E.; Herold, B.C. 2003: Development of topical microbicides for prevention of human immunodeficiency virus and herpes simplex virus American Journal of Reproductive Immunology 49(5): 279-284
Sabidó, M.; Lahuerta, M.; Montoliu, A.; Gonzalez, V.; Hernández, G.; Giardina, F.; Monzón, J.é E.; Pedroza, M.I.; Casabona, J. 2011: Human immunodeficiency virus, sexually transmitted infections, and risk behaviors among clients of sex workers in Guatemala: are they a bridge in human immunodeficiency virus transmission? Sexually Transmitted Diseases 38(8): 735-742
Yusim, K.; Peeters, M.; Pybus, O.G.; Bhattacharya, T.; Delaporte, E.; Mulanga, C.; Muldoon, M.; Theiler, J.; Korber, B. 2001: Using human immunodeficiency virus type 1 sequences to infer historical features of the acquired immune deficiency syndrome epidemic and human immunodeficiency virus evolution Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 356(1410): 855-866
Rasheed, S.; Li, Z.; Xu, D.; Kovacs, A. 1996: Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women American Journal of Obstetrics and Gynecology 175(1): 122-129
Herold, B.C.; Scordi-Bello, I.; Cheshenko, N.; Marcellino, D.; Dzuzelewski, M.; Francois, F.; Morin, R.; Casullo, V.Mas.; Anderson, R.A.; Chany, C.; Waller, D.P.; Zaneveld, L.J.D.; Klotman, M.E. 2002: Mandelic acid condensation polymer: novel candidate microbicide for prevention of human immunodeficiency virus and herpes simplex virus entry Journal of Virology 76(22): 11236-11244
Lätzsch, I. 1988: Human immunodeficiency virus (HIV). 2: HIV infections caused by accidental exposure in medical personnel Zeitschrift für Arztliche Fortbildung 82(12): 553-556
Pandhi, D.; Agrawal, S.K.; Singal, A. 2003: Knowledge of human immunodeficiency virus and post exposure prophylaxis amongst junior doctors Journal of Communicable Diseases 35(3): 218-223
Anonymous 1988: 1988 agent summary statement for human immunodeficiency virus and report on laboratory-acquired infection with human immunodeficiency virus Morbidity and Mortality Weekly Report 37(S-4): 22
Franke, M.F.; Stulac, S.N.; Rugira, I.H.; Rich, M.L.; Bucyibaruta, J.B.; Drobac, P.C.; Iyamungu, G.; Bryant, C.M.; Binagwaho, A.; Farmer, P.E.; Mukherjee, J.S. 2011: High human immunodeficiency virus-free survival of infants born to human immunodeficiency virus-positive mothers in an integrated program to decrease child mortality in rural Rwanda Pediatric Infectious Disease Journal 30(7): 614-616
Monteiro, J.P.; Freimanis-Hance, L.; Faria, L.B.; Mussi-Pinhata, M.M.; Korelitz, J.; Vannucchi, H.él.; Queiroz, W.; Succi, R.C.M.; Hazra, R. 2009: Both human immunodeficiency virus-infected and human immunodeficiency virus-exposed, uninfected children living in Brazil, Argentina, and Mexico have similar rates of low concentrations of retinol, beta-carotene, and vitamin e Nutrition Research 29(10): 716-722
Kidangazhiayathmana, A. 2011: Is Kerala remaining low prevalent in human immunodeficiency virus by accident? a study of risk factors in acquiring human immunodeficiency virus infection in patients attending Anti-retroviral treatment clinic Indian Journal of Dermatology Venereology and Leprology 77(6): 729
1997: From the Centers for Disease Control and Prevention. Recommendations for follow-up of health-care workers after occupational exposure to hepatitis C virus JAMA 278(13): 1056-1057